Screening for Brain Aneurysm in Patients with Family History
Screening for brain aneurysm is strongly recommended for patients who have a first-degree relative (such as a sister) who died of an aneurysm, especially at a young age like 28. 1, 2
Risk Assessment for Familial Aneurysms
The risk of harboring an unruptured intracranial aneurysm (UIA) is significantly elevated in first-degree relatives of individuals with aneurysms:
- First-degree relatives have a prevalence of 4-8.7% of harboring UIAs 2
- Siblings have a higher likelihood of detection than children of affected individuals 2
- The American Heart Association/American Stroke Association guidelines specifically identify family history of intracranial aneurysm as a reason to more strongly consider evaluation 1
Screening Recommendations
Who Should Be Screened
- First-degree relatives (siblings, children, parents) of individuals who had aneurysmal subarachnoid hemorrhage
- Risk is particularly high if:
Screening Method
MRA (Magnetic Resonance Angiography) is the preferred initial screening tool:
CTA (Computed Tomography Angiography) is an acceptable alternative:
DSA (Digital Subtraction Angiography) should be used:
Timing and Frequency
- Initial screening should begin around age 30 2
- For your patient with a sister who died at age 28, screening should be initiated promptly
- If initial screening is negative, repeat screening is recommended every 5-7 years 2
- Screening should continue throughout adulthood 2, 4
Additional Considerations
Risk Modification
All patients with family history of aneurysm should be advised to:
- Quit smoking (smoking increases risk significantly) 2, 3
- Control blood pressure 2
- Be educated about warning signs of aneurysm rupture 2
Treatment Decisions
If an aneurysm is detected:
- Treatment decisions should consider aneurysm size, location, patient age, and comorbidities 1
- Small aneurysms (<7mm) in the anterior circulation generally have low rupture rates 2
- The treating physician should consider both their own experience and the volume of cases at their center when making recommendations 1
Potential Pitfalls and Caveats
False negatives: Both MRA and CTA have limitations in detecting small aneurysms (<3mm) 1
Psychological impact: Screening may cause anxiety; patients should be counseled about this before testing 5
Insurance implications: Detection of an aneurysm may affect life insurance eligibility 5
Treatment risks: If an aneurysm is detected, treatment carries its own risks that must be weighed against the natural history of the aneurysm 1
Center expertise: For both screening interpretation and potential treatment, high-volume centers (>20 cases annually) have better outcomes 1
In summary, given your patient's family history of a sister who died from an aneurysm at age 28, screening with MRA is strongly recommended, with follow-up screening at regular intervals if the initial screen is negative.